{"id":"NCT02248480","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan","officialTitle":"Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Osteoarthritis and Knee Pain in Japan","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10","primaryCompletion":"2015-06","completion":"2015-06","firstPosted":"2014-09-25","resultsPosted":"2017-01-16","lastUpdate":"2019-09-26"},"enrollment":354,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis of the Knee"],"interventions":[{"type":"DRUG","name":"Duloxetine","otherNames":["LY248686"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Duloxetine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The main purpose of this study is to evaluate the efficacy of the study drug known as duloxetine in participants with chronic osteoarthritis (OA) and knee pain in Japan.","primaryOutcome":{"measure":"Change From Baseline on the Brief Pain Inventory (BPI) 24-Hour Average Pain Score","timeFrame":"Baseline, Week 14","effectByArm":[{"arm":"Duloxetine","deltaMin":-2.57,"sd":0.12},{"arm":"Placebo","deltaMin":-1.8,"sd":0.12}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":26},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["36269595","32245696","32021407","31505082","30464579","30126675","29713194"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":178},"commonTop":["Nasopharyngitis","Somnolence","Constipation","Thirst","Nausea"]}}